It's almost impossible to turn on the tube these days without seeing an ad from a drug company. The typical scenario goes something like this: Person with a disease or problem is all smiles, thanks to the benefits of the advertised drug. But there's a catch.
Forest Laboratories has announced it will discontinue sale of NAMENDA tablets on August 15. The company will continue to sell the oral solution of NAMENDA and once-daily extended release capsules.
More than 110 million Americans watched yesterday's Super Bowl in New Orleans. It's not too hard to see why the game has become our nation's defining cultural ritual. The National Football League also could give us the nation's best chance at progress against Alzheimer's disease.
Alzheimer's medications typically used only in early stages of the disease can be more useful in later, more severe stages of dementia than previously thought, a new study suggests.